… This meta-analysis included primarily patients with cardiovascular (not cerebrovascular)
disease. The comparison of antiplatelet therapies in patients with TIA/stroke was performed only …

… Therapy (DAPT) Study, continuation of dual antiplatelet therapy beyond 12 … dual antiplatelet
therapy on mortality by doing a meta-analysis of all randomised, controlled trials of treatment …

… This meta-analysis helps overcome some of the many limitations of … antiplatelet therapy.
Our findings support the use of these assays to aid with the selection of the antiplatelet treatment …

RESEARCH Page 1 Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet
treatment with clopidogrel: systematic review and meta-analysis Tim Bauer research …

… In conclusion, our meta-analysis suggested that antiplatelet therapy might … analysis ( Table
2 ). Our HR and/or OR values describing the relationship between antiplatelet treatment and …

… review and meta-analysis to investigate the effect of antiplatelet treatments on patients with
… Meta-analysis and statistical analyses were completed with using the RevMan 5.3 and Stata …

… The aim of this systematic review and meta-analysis was to compare very short versus > 3
months’ duration of dual antiplatelet treatment (DAPT) in patients undergoing PCI with DES, …

… -guided antiplatelet treatment primarily based on CYP2C19 LOF alleles had a significantly
lower risk of MACE, stent thrombosis and MI compared with the conventional treatment. The …

… to use intensified antiplatelet protocols in … meta-analysis suggests that in patients undergoing
PCI who have HTPR on ADP-specific platelet function testing, more potent antiplatelet …

… antiplatelet treatment with placebo or no treatment were included. 12 trials (3,118 participants)
started antiplatelet … we observed for antiplatelet treatment on vascular access maturation, …